Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2005-10-19 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-ETIENNE-DU-ROUVRAY (76800), Seine-Maritime
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE GROSLEY : revenue, balance sheet and financial ratios
PHARMACIE GROSLEY is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-ETIENNE-DU-ROUVRAY (76800),
this company of category PME
shows in 2025 a net income positive of 139 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE GROSLEY (SIREN 484955372)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
139 220 €
127 476 €
141 201 €
152 136 €
119 560 €
141 285 €
114 635 €
148 149 €
209 861 €
199 204 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE GROSLEY generates positive net income of 139 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 199 k€ -> 139 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
139 220 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 59%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
59.105%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
53.682%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
38.488
31.553
376.243
317.188
211.265
152.441
137.69
110.323
83.483
59.105
Financial autonomy
65.423
68.812
19.013
21.253
28.788
35.143
37.132
40.844
47.524
53.682
Repayment capacity
None
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
59.12025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average-8 pts over 3 years
In 2025, the debt ratio of PHARMACIE GROSLEY (59.10) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
53.68%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average+10 pts over 3 years
In 2025, the financial autonomy of PHARMACIE GROSLEY (53.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 224.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
224.319
Liquidity indicators evolution PHARMACIE GROSLEY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
274.526
299.498
338.144
282.738
315.598
301.784
269.201
205.332
235.976
224.319
Interest coverage
None
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
224.322025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Good+9 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE GROSLEY (224.32) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE GROSLEY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE GROSLEY is estimated at
2 211 526 €
(range 1 500 752€ - 3 470 189€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1500k€2211k€3470k€
2 211 526 €Range: 1 500 752€ - 3 470 189€
NAF 5 année 2025
Valuation method used
Net Income Multiple
139 220 €
×
15.9x
=2 211 526 €
Range: 1 500 752€ - 3 470 189€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE GROSLEY with other companies in the same sector:
Frequently asked questions about PHARMACIE GROSLEY
What is the revenue of PHARMACIE GROSLEY ?
The revenue of PHARMACIE GROSLEY is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE GROSLEY profitable?
Yes, PHARMACIE GROSLEY generated a net profit of 139 k€ in 2025.
Where is the headquarters of PHARMACIE GROSLEY ?
The headquarters of PHARMACIE GROSLEY is located in SAINT-ETIENNE-DU-ROUVRAY (76800), in the department Seine-Maritime.
Where to find the tax return of PHARMACIE GROSLEY ?
The tax return of PHARMACIE GROSLEY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE GROSLEY operate?
PHARMACIE GROSLEY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart